Back to Search
MATTHEW NEAL, OD
OD
Optometrist
NPI: 1518930064IndividualAccepts Medicare
Specialties, Licenses & Credentials
OptometristPrimary
Optometrist
Code: 152W00000X
5232(OH)T2136(OH)2778(CO)
CMS Specialties
PrimaryOPTOMETRY
Education
OHIO STATE UNIVERSITY - COLLEGE OF OPTOMETRY
Class of 2001
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial.
PMID 39250922·Lancet Diabetes Endocrinol·2024
4-observational
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.
PMID 37979717·Chest·2024
2-rct
Antiplatelet agents for the treatment of adults with COVID-19.
PMID 37489818·Cochrane Database Syst Rev·2023
1-meta
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.
PMID 37356038·Circulation·2023
2-rct
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
PMID 37227729·JAMA Netw Open·2023
2-rct
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
PMID 36942550·JAMA·2023
8-other
Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
PMID 35060325·Clin Respir J·2022
8-other
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
PMID 35040887·JAMA·2022
4-observational
Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study.
PMID 34934895·Res Pract Thromb Haemost·2021
8-other
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial.
PMID 34904132·JACC Basic Transl Sci·2021
8-other
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
PMID 34473343·Cochrane Database Syst Rev·2021
1-meta
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
PMID 34351722·N Engl J Med·2021
4-observational
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
PMID 34351721·N Engl J Med·2021
4-observational
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
PMID 34302745·Lancet Diabetes Endocrinol·2021
3-trial
COVID-19 Complicated by Acute Pulmonary Embolism.
PMID 33778561·Radiol Cardiothorac Imaging·2020
8-other
Prophylactic anticoagulants for people hospitalised with COVID-19.
PMID 33502773·Cochrane Database Syst Rev·2020
1-meta
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.
PMID 32766543·EClinicalMedicine·2020
8-other
Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data.
PMID 32613083·Wellcome Open Res·2020
8-other
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
PMID 32492712·Blood·2020
3-trial
Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank.
PMID 32466757·BMC Med·2020
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8383 W ALAMEDA AVE
LAKEWOOD, CO 80226 - Phone
- (303) 338-4545
Quick Facts
- NPI
- 1518930064
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 25
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile